We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDL icon
9351
Flanigan's Enterprises
BDL
$77.6M
$3K ﹤0.01%
90
-770
-90% -$23.7K
BON
9352
Bon Natural Life
BON
$8.94M
$3K ﹤0.01%
4
-7
-64% -$6.53K
BORR
9353
Borr Drilling
BORR
$1.24B
$3K ﹤0.01%
909
-7,204
-89% -$18.4K
CCRV
9354
DELISTED
iShares Commodity Curve Carry Strategy ETF
CCRV
$3K ﹤0.01%
+116
New +$2.95K
CDIO icon
9355
Cardio Diagnostics
CDIO
$4.62M
$3K ﹤0.01%
+10
New +$2.96K
CELG.RT
9356
Bristol-Myers Squibb Rights
CELG.RT
$191M
$3K ﹤0.01%
22,101
+22,083
+122,683% +$3.6K
MBAI
9357
Check-Cap
MBAI
$8.19M
$3K ﹤0.01%
415
+288
+227% +$3.02K
COGT icon
9358
Cogent Biosciences
COGT
$6.65B
$3K ﹤0.01%
+419
New +$2.92K
CORN icon
9359
Teucrium Corn Fund
CORN
$176M
$3K ﹤0.01%
109
-1,440
-93% -$34.6K
DOCT
9360
FT Vest US Equity Deep Buffer ETF October
DOCT
$385M
$3K ﹤0.01%
98
-1,353
-93% -$43.8K
DZZ icon
9361
DB Gold Double Short ETN due Feb 15 2038
DZZ
$3.42M
$3K ﹤0.01%
1,272
-226
-15% -$575
EPR.PRE icon
9362
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$113M
$3K ﹤0.01%
78
-33
-30% -$1.1K
EVLV icon
9363
Evolv Technologies
EVLV
$995M
$3K ﹤0.01%
1,000
-14,950
-94% -$48.9K
FBRX icon
9364
Forte Biosciences
FBRX
$1.57B
$3K ﹤0.01%
87
-374
-81% -$14.2K
FLSP icon
9365
Franklin Systematic Style Premia ETF
FLSP
$1.04B
$3K ﹤0.01%
+142
New +$3.05K
FQAL icon
9366
Fidelity Quality Factor ETF
FQAL
$1.41B
$3K ﹤0.01%
53
-256
-83% -$13.3K
FSTR icon
9367
Foster
FSTR
$430M
$3K ﹤0.01%
212
-84
-28% -$1.27K
FXNC icon
9368
First National Corp
FXNC
$287M
$3K ﹤0.01%
129
-200
-61% -$4.38K
GDEVW icon
9369
GDEV Inc Warrant
GDEVW
$42.5K
$3K ﹤0.01%
2,573
-400
-13% -$315
GEG icon
9370
Great Elm Group
GEG
$67.4M
$3K ﹤0.01%
1,745
-83
-5% -$162
GTEK icon
9371
Goldman Sachs Future Tech Leaders Equity ETF
GTEK
$226M
$3K ﹤0.01%
100
-93
-48% -$3.04K
HLLY.WS
9372
DELISTED
Holley Inc Warrants
HLLY.WS
$3K ﹤0.01%
643
-500
-44% -$1.78K
HL.PRB icon
9373
Hecla Mining Co Series B Preferred Stock
HL.PRB
$10.1M
$3K ﹤0.01%
46
-92
-67% -$5.51K
HYPR icon
9374
Hyperfine
HYPR
$92.9M
$3K ﹤0.01%
851
+559
+191% +$2.31K
IBHE
9375
DELISTED
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
$3K ﹤0.01%
138
-261
-65% -$6.34K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.